Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery

British Journal of Ophthalmology

Volumn 91, Issue 10, 2007, Pages 1350-1353

  Murphy, Conor C ^a   Nicholson, Steven ^a   Quah, Say Aun ^a   Batterbury, Mark ^a   Neal, Timothy ^a   Kaye, Stephen B ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CHLORAMPHENICOL; VANCOMYCIN;

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; ENDOPHTHALMITIS; FEMALE; HUMAN; IMMUNOASSAY; MALE; MINIMUM INHIBITORY CONCENTRATION; PHACOEMULSIFICATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; ENDOPHTHALMITIS; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INJECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; VANCOMYCIN;

EID: 34848908383     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.112060     Document Type: Article

References (28)

1. Morlet NM, Li J, Semmens J, et al. The Endophthalmitis Population Study of Western Australia (EPSWA): first report. Br J Ophthalmol 2003;87:574-6.
2. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. medicare population increased between 1994 and 2001. Ophthlmology 2005;112:1388-94.
3. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis after cataract surgery. Arch Ophthlamol 2005;123:613-20.
4. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-10.
5. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
6. Ferro JF, de-Pablos M, Lograno MJ, et al. Postoperative contamination after using vancomycin and gentamicin during phacoemulsification. Arch Ophthalmol 1997;115:165-70.
7. Pflugfelder SC, Hernandez E, Fliesler SJ, et al. Intravitreal vancomycin: retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol 1987;105:831-7.
8. Wejde G, Montan P, Lundstrom M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand 2005;83:7-10.
9. Meredith TA. Antibiotics and antifungals. In: Zimmerman TJ, eds. Textbook of ocular pharmacology. Philadelphia: Lippincott-Raven Publishers, 1997:363-85.
10. Wilson J, Davis A, Tobin C. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment. J Antib Chemo 2003;52:78-82.
11. Gills JP. Filters and antibiotics in irrigating solution for cataract surgery. J Cataract Refract Surg 1991;17:385.
12. Feys J, Salvanet-Bouccara A, Emond JP, et al. Vancomycin prophylaxis and intraocular contamination during cataract surgery. J Cataract Refract Surg 1997;23:894-7.
13. Grill DC, Cevallos AV, Smolin G, et al. Antibiotic supplementation of intraocular irrigation solutions; an in vitro model of antibacterial action. Ophthalmology 1996;103:1204-8.
14. Mendivil AS, Mendivil MP. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol 2001;131:293-300.
15. Schoenwald RD. Ocular pharmacokinetics. In: Zimmerman TJ, ed. Textbook of ocular pharmacology. Philadelphia: Lippincott-Raven Publishers, 1997:119-38.
16. Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 2006;42:S35-39.
17. Oh C, Saville BA, Cheng Y, et al. A compartment model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm Res 1995;12:433-7.
18. Lehmann OJ, Thompson JP, White LO, et al. Half-life of intracameral gentamicin after phacoemulsification. J Cataract Refract Surg 1997;23:883-8.
19. Montan PG, Wejde G, Setterquist H, et al. Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 2002;28:982-7.
20. Mayers M, Rush D, Madu A, et al. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob Agents Chemother 1991;35:1791-8.
21. Libre P, Della-Latta P, Chin N. Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model. J Catarct Refract Surg 2003;29:1791-4.
22. Kodjikian L, Burillon C, Garweg JG. Intracameral vancomycin and endophthalmitis prophylaxis. J Cataract Refract Surg 2004;30:2030.
23. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227-31.
24. Rybak MJ, Bailey EM, Lamp KC, et al. Pharmacokinetics and bactericidal rates of daptomycin ana vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteraemia. Antimicrob Agents Chemother 1992;36:1109-14.
25. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol 1991;112:278-82.
26. Beigi B, Westlake W, Chang B, et al. The effect of intracameral perioperative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification. Eye 1998;12:390-4.
27. Gordon YJ. Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? Am J Ophthalmol 2001;131:371-6.
28. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 1999;106:1660-4.